• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Health Care Provider Knowledge and Attitudes Regarding Adult Pneumococcal Conjugate Vaccine Recommendations - United States, September 28-October 10, 2022
MMWR Morb Mortal Wkly Rep. 2023 Sep 8;72(36):979-984. doi: 10.15585/mmwr.mm7236a2.ABSTRACTDespite the availability of effective vaccines against pneumococcal disease, pneumococcus is a common bacterial cause of pneumonia, causing approximately 100,000 hospitalizations among U.S. adults per year. In addition, approximately 30,000 invasive pneumococcal disease (IPD) cases and 3,000 IPD deaths occur among U.S. adults each year. Previous health care provider surveys identified gaps in provider knowledge about and understanding of the adult pneumococcal vaccine recommendations, and pneumococcal vaccine coverage remains suboptim...
Source: MMWR Morb Mortal Wkl... - September 7, 2023 Category: Epidemiology Authors: Rebecca Kahn Lindsay Zielinski Amber Gedlinske Natoshia M Askelson Christine Petersen Andrew M Parker Courtney A Gidengil Alison P Albert Angela J Jiles Megan C Lindley Miwako Kobayashi Aaron M Scherer Source Type: research

Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023
MMWR Recomm Rep. 2023 Sep 8;72(3):1-39. doi: 10.15585/mmwr.rr7203a1.NO ABSTRACTPMID:37669242 | DOI:10.15585/mmwr.rr7203a1
Source: MMWR Recomm Rep - September 5, 2023 Category: Epidemiology Authors: Miwako Kobayashi Tamara Pilishvili Jennifer L Farrar Andrew J Leidner Ryan Gierke Namrata Prasad Pedro Moro Doug Campos-Outcalt Rebecca L Morgan Sarah S Long Katherine A Poehling Adam L Cohen Source Type: research

Incidence and clinical outcomes of pneumonia in persons with down syndrome in the United States
CONCLUSIONS: Among persons with DS, incidence of pneumonia and associated hospitalizations were increased; mortality among those with pneumonia was comparable at 30 days, but higher at 1 year. DS should be considered an independent risk condition for pneumonia.PMID:37328350 | DOI:10.1016/j.vaccine.2023.05.063
Source: Vaccine - June 16, 2023 Category: Allergy & Immunology Authors: Edward N Janoff Hung-Fu Tseng Jennifer L Nguyen Tamuno Alfred Jeffrey Vietri Angee McDaniel Erica Chilson Qi Yan Deepa Malhotra Raul E Isturiz Myron J Levin Source Type: research

Vaccine co-administration in adults: An effective way to improve vaccination coverage
Hum Vaccin Immunother. 2023 Apr 11:2195786. doi: 10.1080/21645515.2023.2195786. Online ahead of print.ABSTRACTThe ongoing COVID-19 pandemic highlights that complications and mortality associated with infectious diseases increase with age. Various vaccines are recommended for adults, but coverage rates remain suboptimal. Although co-administration would improve vaccine uptake and timely immunization, this is not routine practice in adults. We review key data on co-administration of vaccines in children and adults to reassure healthcare providers about its safety and advantages. In European countries and the United States, c...
Source: Herpes - April 11, 2023 Category: Infectious Diseases Authors: Paolo Bonanni Robert Steffen J örg Schelling Lina Balaisyte-Jazone Inga Posiuniene Maciej Zato ński Pierre Van Damme Source Type: research

Public health impact and cost-effectiveness of 15-valent pneumococcal conjugate vaccine use among the pediatric population of the United States
CONCLUSIONS: A further decrease in pneumococcal disease in conjunction with considerable societal cost savings could be expected from replacing PCV13 with PCV15 within the routine infant immunization program in the United States.PMID:37012118 | DOI:10.1016/j.vaccine.2023.03.045
Source: Vaccine - April 3, 2023 Category: Allergy & Immunology Authors: Namrata Prasad Charles Stoecker Wei Xing Bo-Hyun Cho Andrew J Leidner Miwako Kobayashi Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13